Literature DB >> 11161441

CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression.

S Takeshita1, F Takeshita, D E Haddad, K J Ishii, D M Klinman.   

Abstract

Intramuscular injection of synthetic oligodeoxynucleotides (ODN) expressing unmethylated CpG motifs trigger the rapid development of a local inflammatory response. In vitro studies demonstrate that macrophages exposed to CpG ODN up-regulate expression of mRNA encoding the chemokines MIP-1alpha, MIP-1beta, MIP-2, RANTES, JE/MCP-1, and IP-10. Within 6 h of in vivo administration, CpG ODN induce a significant increase in chemokine mRNA levels at the site of injection and draining lymph nodes. These chemokines may contribute to the migration and stimulation of inflammatory cells that contribute to the development of CpG ODN-induced immune responses. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11161441     DOI: 10.1006/cimm.2000.1735

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

Authors:  Sven Klaschik; Debra Tross; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

2.  Unmethylated CpG oligodeoxynucleotides activate head kidney leukocytes of Atlantic cod, Gadus morhua.

Authors:  Christopher Marlowe A Caipang; Sanchala Gallage; Carlo C Lazado; Monica F Brinchmann; Viswanath Kiron
Journal:  Fish Physiol Biochem       Date:  2010-03-28       Impact factor: 2.794

3.  Short- and long-term changes in gene expression mediated by the activation of TLR9.

Authors:  Sven Klaschik; Debra Tross; Hidekazu Shirota; Dennis M Klinman
Journal:  Mol Immunol       Date:  2009-12-14       Impact factor: 4.407

4.  The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.

Authors:  Jan L Bjersing; Kristina Eriksson; Andrej Tarkowski; L Vincent Collins
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

5.  Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.

Authors:  Susana Mendez; Khaled Tabbara; Yasmine Belkaid; Sylvie Bertholet; Daniela Verthelyi; Dennis Klinman; Robert A Seder; David L Sacks
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

6.  Epitope-based vaccination against pneumonic tularemia.

Authors:  Stephen H Gregory; Stephanie Mott; Jennifer Phung; Jinhee Lee; Leonard Moise; Julie A McMurry; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

7.  CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection.

Authors:  Jane C Deng; Thomas A Moore; Michael W Newstead; Xianying Zeng; Arthur M Krieg; Theodore J Standiford
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

8.  Molecular mechanism of immune response induced by foreign plasmid DNA after oral administration in mice.

Authors:  Jian-Wen Liu; Jun Cheng
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

9.  A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.

Authors:  Ali M Harandi; Kristina Eriksson; Jan Holmgren
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN.

Authors:  Sanjay Sharma; Constantine P Karakousis; Hiroshi Takita; Kyu Shin; Stephen P Brooks
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.